- Home
- RVSN vs QNTM Comparison
RVSN vs QNTM Comparison
Compare RVSN & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSN
- QNTM
- Stock Information
- Founded
- RVSN 2016
- QNTM 1998
- Country
- RVSN Israel
- QNTM Canada
- Employees
- RVSN N/A
- QNTM N/A
- Industry
- RVSN
- QNTM
- Sector
- RVSN
- QNTM
- Exchange
- RVSN Nasdaq
- QNTM NYSE
- Market Cap
- RVSN 9.4M
- QNTM 9.1M
- IPO Year
- RVSN 2022
- QNTM N/A
- Fundamental
- Price
- RVSN $1.09
- QNTM $3.42
- Analyst Decision
- RVSN
- QNTM
- Analyst Count
- RVSN 0
- QNTM 0
- Target Price
- RVSN N/A
- QNTM N/A
- AVG Volume (30 Days)
- RVSN 18.2M
- QNTM 223.5K
- Earning Date
- RVSN 02-03-2025
- QNTM 01-28-2025
- Dividend Yield
- RVSN N/A
- QNTM N/A
- EPS Growth
- RVSN N/A
- QNTM N/A
- EPS
- RVSN N/A
- QNTM N/A
- Revenue
- RVSN $903,000.00
- QNTM N/A
- Revenue This Year
- RVSN $1,344.37
- QNTM N/A
- Revenue Next Year
- RVSN $1,143.30
- QNTM N/A
- P/E Ratio
- RVSN N/A
- QNTM N/A
- Revenue Growth
- RVSN 347.03
- QNTM N/A
- 52 Week Low
- RVSN $0.38
- QNTM $2.70
- 52 Week High
- RVSN $23.37
- QNTM $70.85
- Technical
- Relative Strength Index (RSI)
- RVSN 48.11
- QNTM 41.28
- Support Level
- RVSN $1.05
- QNTM $3.20
- Resistance Level
- RVSN $1.77
- QNTM $3.55
- Average True Range (ATR)
- RVSN 0.47
- QNTM 0.43
- MACD
- RVSN -0.09
- QNTM -0.00
- Stochastic Oscillator
- RVSN 11.36
- QNTM 14.97
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.